ReviewCurrent cardiology reports2018

HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?

I Karalis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.